Injective Holds Above $6.40 After 5% Pullback
Injective Holds Above $6.40 After 5% Pullback – Breakout Structure Faces Key Retest
Key Takeaways
- Injective rebounded from a low near $2.61 and broke above the $6.29 resistance level.
- After rallying above $7.00, INJ pulled back 5 percent as short term holders took profits.
- Trading volume reached $220 million over 24 hours, despite a 12.8 percent decline.
- Total value locked rose 7.82 percent to $12.81 million during the latest move.
- The $6.40 to $6.29 zone is now a key support area for maintaining the bullish structure.
Recovery From Prolonged Downtrend Sets the Stage for Breakout
Injective spent much of the past year in a sustained downtrend, falling from levels above $18 to a low near $2.61. Over time, selling pressure eased as buyers absorbed supply around the bottom range. This process allowed a recovery structure to develop, with accumulation gradually strengthening.
The turning point came when INJ pushed through the $6.29 level. That price had repeatedly acted as resistance, rejecting earlier recovery attempts. The breakout above this barrier marked a shift in market structure. Price briefly advanced to $7.14, supported by rising volume and broader participation.
The move indicated that traders were willing to reenter the market at higher levels after the prolonged decline. Breaking a resistance level that has held multiple times typically changes its technical role, making it relevant as potential support in future pullbacks.
5 Percent Pullback Linked to Profit Taking and Bitcoin Correction
After reaching levels above $7.00, Injective entered a short consolidation phase. The token declined by 5 percent, with recent price candles reflecting hesitation among market participants.
According to the available data, short term holders began locking in profits following the rally. This coincided with a corrective phase in Bitcoin, which often influences broader crypto market sentiment. The pullback occurred despite the broader bullish structure remaining intact.
Momentum indicators continued to show strength. The Relative Strength Index stood near 69 at the time of reporting, indicating that buying pressure remained dominant even as price cooled from recent highs. The retracement has therefore not yet disrupted the recovery pattern established after the breakout.
Trading Volume and TVL Signal Continued Market Participation
Beyond price action, market participation provides additional insight into the sustainability of the move. Trading volume over the past 24 hours reached $220 million, although this represented a 12.8 percent decline compared to the prior period.
Despite the drop, the level of activity remained elevated during the breakout and subsequent pullback. This suggests that traders continued to engage with the asset during the consolidation phase rather than exiting entirely.
On chain metrics also showed growth. Injective’s total value locked stood at approximately $12.81 million, reflecting a 7.82 percent increase over the same period. Rising TVL indicates that capital continued to flow into the ecosystem even as price retraced from its recent high.
The alignment between elevated trading activity and rising TVL points to sustained engagement across both exchange markets and on chain usage. For market participants, this combination can help assess whether price movements are supported by underlying activity.
$6.40 to $6.29 Becomes Critical Support Zone
Following the breakout, attention has shifted to whether former resistance can hold as support. The $6.40 to $6.29 region now represents a key technical area.
Earlier in the move, buyers overwhelmed sellers near $6.40, triggering an advance above $7.00 and eventually to $7.35. As momentum peaked, early participants secured profits, leading to a rejection from higher levels and a return toward $6.59.
The current pullback has not broken the broader structure formed after a roughly 27 percent rally from $5.80. Instead, it reflects a consolidation phase after a strong upward move that absorbed nearby liquidity.
If buyers defend the $6.29 level during this retest, it would confirm that resistance has effectively turned into support. In that case, price could revisit $7.35 and potentially approach the $7.80 to $8.90 range mentioned in the analysis. Conversely, a failure to hold $6.40 would increase the likelihood of a deeper retracement toward the $6.00 to $6.20 demand zone.
For traders and platform users who track short term volatility, these levels define the current risk boundaries. The reaction around $6.40 and $6.29 will determine whether the breakout remains structurally intact or transitions into a broader correction.
Our Assessment
Injective has recovered from a prolonged decline and established a breakout above the $6.29 resistance level. Although the token has pulled back 5 percent amid profit taking and a broader Bitcoin correction, trading volume remains elevated and total value locked has increased to $12.81 million. The $6.40 to $6.29 range now serves as the primary support zone. Holding this level would preserve the current bullish structure, while a breakdown would shift focus toward lower demand zones around $6.00.
We have imposed strict editorial guidelines on ourselves and explain our testing methods openly and comprehensively. We also communicate transparently how our work is financed. This site may contain tracking links, but this does not influence our objective view in any way.
